ArticleComputers in biology and medicine2025
Explainable transformer-based deep survival analysis in childhood acute lymphoblastic leukemia.
Article in Computers in biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Knowledge-guided learning with curated prior genetic biomarkers for robust model interpretation.Bioinformatics (Oxford, England) · 2026Article
- Article
- Recent advances in deep learning for leukemia diagnosis: a scoping review of diagnostic modalities and fusion-based approaches.Frontiers in digital health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAcute lymphoblastic leukemia (ALL) is the most common type of leukemia among children and adolescents and can be life-threatening. The incidence of new cases has been increasing in recent years. Developing a predictive model to forecast the risk of death can help improve survival rates by enabling clinicians to provide timely and effective treatments. Traditional statistical survival models are limited by predefined assumptions, while current deep survival models, despite their flexibility, struggle with capturing complex and dynamic feature dependencies. Transformers provide a promising solution by using self-attention and multi-head attention mechanisms to overcome these challenges. Moreover, building on recent work in interpretable medical AI, the combination of Transformers and explainable methods can quantify the contributions of each feature to the survival probability prediction.
methodsThis paper proposes an explainable Transformer-based deep survival model to predict patient-specific survival probabilities for ALL. The model combines feedforward networks with Transformer architecture and is trained to minimize a loss function that measures the difference between predicted and actual survival outcomes. In addition, we use Shapley Additive Explanations (SHAP) to interpret the contributions of clinical attributes to the predictions, providing insights from both global and local perspectives.
resultsThe proposed model demonstrates robustness by consistently providing higher average survival probabilities for censored patients compared to deceased patients. It achieves an average concordance index (C-index) of 0.945, demonstrating strong predictive accuracy. Through SHAP analysis, we identify three key factors affecting survival outcomes, namely prognosis status, diagnosis year, and histology. Experiment results reveal that our model outperforms state-of-the-art deep survival models in terms of C-index when these important variables are included.
conclusionThe proposed explainable Transformer-based deep survival model shows strong potential for providing accurate patient-specific survival predictions for ALL. Moreover, the insights gained from SHAP improve the model's interpretability for clinicians, helping them make better-informed decisions regarding prognosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.